Alzheimer Disease: Diffusion Tensor MRI and amyloid PET

Alzheimer Disease: Diffusion Tensor MRI and a...

Up next

Imaging in Advanced Epithelial Ovarian Cancer

Dr. Refky Nicola speaks with Dr. Atul Shinagare about his team's research showing that incidental adnexal lesions on single‑phase CT are often difficult for radiologists to classify consistently, with only certain classic lesions yielding strong agreement. Their conversation unde ...  Show more

Inside PSMA PET Frameworks

Dr. Ashwin Parihar speaking with Drs. Sungmin Woo and Alberto Vargas about why standardized PSMA PET scoring systems—such as PSMA‑RADS and PROMISE—are becoming essential for consistent interpretation, communication, and treatment planning in prostate cancer. They explore the evid ...  Show more

Recommended Episodes

Neurologist Faces His Alzheimer Diagnosis Determined to Lessen Stigma Surrounding the Disease
JAMA Medical News

In this Medical News podcast, Rita Rubin interviews retired neurologist Daniel Gibbs, MD, about his efforts to lessen the stigma surrounding Alzheimer disease, which he was diagnosed with 5 years ago. Related Content: Neurologist Faces His Alzheimer Diagnosis Determined to Lessen ...  Show more

Dementia vs Alzheimer's: Signs, symptoms and preventing Alzheimer's disease with Lisa McGuire, PhD
AMA Update

Following National Alzheimer’s Disease Awareness Month, the CDC shares what physicians and patients need to know about the disease. Lisa McGuire, PhD, lead epidemiologist at the CDC, discusses the importance of catching Alzheimer’s early, its risk factors and barriers to make Alz ...  Show more

Cortex Anatomy and Alzheimer's Disease
Osher WISE: Well-being and Integrative Science for Everyone (Audio)

There are 6 million Americans living with Alzheimer's Disease. This program explains the latest understanding of the anatomy and functions of the brain and how it relates to neurological diseases. Dr. Gil Rabinovici is at the forefront of novel diagnostic testing to detect Alzhei ...  Show more

Episode 223: ASCO GU 2023: Discussing KEYNOTE-057 with Andrea Necchi, MD
The Uromigos

The Uromigos met with Andrea Necchi, MD at the 2023 ASCO GU Cancers Symposium to discuss results of the phase 2 KEYNOTE-057 study on the use of pembrolizumab monotherapy for patients with high-risk non-muscle-invasive bladder cancer who are unresponsive to bacillus Calmette–Gu ...

  Show more